Cargando…

Optimized pharmacological control over the AAV-Gene-Switch vector for regulable gene therapy

Gene therapy in its current design is an irreversible process. It cannot be stopped in case of unwanted side effects, nor can expression levels of therapeutics be adjusted to individual patient’s needs. Thus, the Gene-Switch (GS) system for pharmacologically regulable neurotrophic factor expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Shi, van Gaalen, Marcel M., Bähr, Mathias, Garea-Rodriguez, Enrique, Kügler, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426472/ https://www.ncbi.nlm.nih.gov/pubmed/34552998 http://dx.doi.org/10.1016/j.omtm.2021.07.007

Ejemplares similares

Long-Term Assessment of AAV-Mediated Zinc Finger Nuclease Expression in the Mouse Brain
por: Zahur, Muzna, et al.
Publicado: (2017)

Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2022)

AAV gene therapy vectors in the TMJ
por: Brouxhon, Sabine M., et al.
Publicado: (2022)

Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue
por: Mingozzi, F, et al.
Publicado: (2013)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics
por: Rodriguez-Estevez, Laura, et al.
Publicado: (2019)

Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2023)

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
por: Srivastava, Arun
Publicado: (2023)

Evaluation of AAV-DJ vector for retinal gene therapy
por: Katada, Yusaku, et al.
Publicado: (2019)

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
por: Eichhoff, Anna Marei, et al.
Publicado: (2019)

Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy
por: Kashiwakura, Yuji, et al.
Publicado: (2023)

Optimization of AAV vectors to target persistent viral reservoirs
por: Colón-Thillet, Rossana, et al.
Publicado: (2021)

Effective delivery of large genes to the retina by dual AAV vectors
por: Trapani, Ivana, et al.
Publicado: (2014)

Nephron segment-specific gene expression using AAV vectors
por: Asico, Laureano D., et al.
Publicado: (2018)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Optimized AAV rh.10 Vectors That Partially Evade Neutralizing Antibodies during Hepatic Gene Transfer
por: Selot, Ruchita, et al.
Publicado: (2017)

Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors
por: Uhrig-Schmidt, Silke, et al.
Publicado: (2014)

Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye
por: Li, Wensheng, et al.
Publicado: (2009)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Engineered AAV vectors for improved central nervous system gene delivery
por: A Kotterman, Melissa, et al.
Publicado: (2015)

Single-dose AAV vector gene immunotherapy to treat food allergy
por: Gonzalez-Visiedo, Miguel, et al.
Publicado: (2022)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

Transcriptional Targeting Approaches in Cardiac Gene Transfer Using AAV Vectors
por: Schröder, Lena C., et al.
Publicado: (2023)

Characterization and biodistribution of under-employed gene therapy vector AAV7
por: Yost, Samantha A., et al.
Publicado: (2023)

Optimized AAV Vectors for TMC1 Gene Therapy in a Humanized Mouse Model of DFNB7/11
por: Marcovich, Irina, et al.
Publicado: (2022)

Switching of serotype can improve local AAV-mediated gene therapy in RA
por: Adriaansen, J, et al.
Publicado: (2004)

GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
por: Hartmann, Jessica, et al.
Publicado: (2019)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
por: Georgiadis, A, et al.
Publicado: (2016)

Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
por: Iwata, Nobuhisa, et al.
Publicado: (2013)

A comparison of AAV-vector production methods for gene therapy and preclinical assessment
por: Davidsson, Marcus, et al.
Publicado: (2020)

AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives
por: Hanaford, Allison R., et al.
Publicado: (2022)

Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production
por: Halbert, Christine L., et al.
Publicado: (2010)

AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells
por: Liu, Bin, et al.
Publicado: (2021)

A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo
por: Zhong, Guocai, et al.
Publicado: (2019)

Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
por: Georgiadis, A., et al.
Publicado: (2018)

AAV1 is the optimal viral vector for optogenetic experiments in pigeons (Columba livia)
por: Rook, Noemi, et al.
Publicado: (2021)

Goody two plasmids: An optimized transient transfection system for AAV vector production
por: Moreno Velasquez, Sergio David, et al.
Publicado: (2023)

A MicroRNA124 Target Sequence Restores Astrocyte Specificity of gfaABC(1)D-Driven Transgene Expression in AAV-Mediated Gene Transfer
por: Taschenberger, Grit, et al.
Publicado: (2017)

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jnbrq7l9jom9tfua3u3830m6do